MENLO PARK, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Susan G. Kim as Chief Financial Officer, effective as of September 28, 2020.
Read this article:
Pacific Biosciences Announces New Chief Financial Officer
WALTHAM, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment of serious chronic diseases, today announced two presentations at the Jefferies Next Generation IBD Therapeutics Virtual Summit. Members of the Morphic management team are scheduled to participate in a panel discussion at 8:45 a.m. ET on Wednesday, September 23, 2020, as well as present a company overview at 1:00 p.m. ET on the same day.
Read more:
Morphic Therapeutic to Present at the Jefferies Next Generation IBD Therapeutics Virtual Summit
Simplify Disc overall success rate of 93.0% was superior to the ACDF control Simplify Disc overall success rate of 93.0% was superior to the ACDF control
View original post here:
Simplify Medical Receives FDA Approval for 1-Level Simplify Disc PMA
PRESS RELEASE
Read the original here:
Saniona announces outcome of warrant exercise
Television Legend Montel Williams Joins Isiah Thomas During Live Q&A
Read the rest here:
One World Pharma Releases Investor Presentation
Orphazyme A/SCompany announcement No. 53/2020 Company Registration No. 32266355
Continue reading here:
New incentive program for the Board of Directors of Orphazyme
Lexicon Has Reduced Its Outstanding Debt by Approximately 90% in Third Quarter 2020 Lexicon Has Reduced Its Outstanding Debt by Approximately 90% in Third Quarter 2020
View original post here:
Lexicon Pharmaceuticals Reaches Agreements to Exchange Convertible Notes, Reduce Outstanding Indebtedness
Resource hub streamlines and simplifies application process for clinical trials within EU Resource hub streamlines and simplifies application process for clinical trials within EU
Visit link:
Parexel Announces Solution for EU Clinical Trials Information System Regulation
BASKING RIDGE, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, chief executive officer, will participate in a fireside chat at the JMP Securities MedTech Bio Summit, which is being held virtually October 1-2, 2020.
Excerpt from:
electroCore to Participate in the JMP Securities MedTech Bio Summit